News
1h
Stocktwits on MSNNovavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval HopesNovavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...
Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5% ...
Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.
Canadian leaders made their final push for votes Sunday, one day before an election dominated by President Donald Trump's ...
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval commitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results